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Abstract
Background: Amyotrophic lateral sclerosis (ALS) is incurable and characterized by progressive paralysis of the muscles of
the limbs, speech and swallowing, and respiration due to the progressive degeneration of voluntary motor neurons.
Clinically indistinguishable ALS can be caused by genetic mutations of Cu/Zn superoxide dismutase (SOD1), TAR-DNA
binding protein 43 (TDP43), or fused in sarcoma/translocated in liposarcoma (FUS/TLS), or can occur in the absence of
known mutation as sporadic disease. In this study, we tested the hypothesis that FUS/TLS and TDP43 gain new pathogenic
functions upon aberrant accumulation in the cytosol that directly or indirectly include misfolding of SOD1.
Methodology/Principal Findings: Patient spinal cord necropsy immunohistochemistry with SOD1 misfolding-specific
antibodies revealed misfolded SOD1 in perikarya and motor axons of SOD1-familial ALS (SOD1-FALS), and in motor axons of
R521C-FUS FALS and sporadic ALS (SALS) with cytoplasmic TDP43 inclusions. SOD1 misfolding and oxidation was also
detected using immunocytochemistry and quantitative immunoprecipitation of human neuroblastoma SH-SY5Y cells as
well as cultured murine spinal neural cells transgenic for human wtSOD1, which were transiently transfected with human
cytosolic mutant FUS or TDP43, or wtTDP43.
Conclusion/Significance: We conclude that cytosolic mislocalization of FUS or TDP43 in vitro and ALS in vivo may kindle
wtSOD1 misfolding in non-SOD1 FALS and SALS. The lack of immunohistochemical compartmental co-localization of
misfolded SOD1 with cytosolic TDP43 or FUS suggests an indirect induction of SOD1 misfolding followed by propagation
through template directed misfolding beyond its site of inception. The identification of a final common pathway in the
molecular pathogenesis of ALS provides a treatment target for this devastating disease.
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Introduction
ALS is characterized by progressive paralysis of the muscles of
the limbs, speech, swallowing and respiration, due to the
progressive degeneration of innervating motor neurons [1].
Certain proteins, mutant and wild-type alike, have been identified
to mislocalize or accumulate as microscopically identifiable
misfolded aggregates that may participate in ALS pathogenesis
[2–4]. Misfolded aggregated proteins and peptides are also
thought to participate in prion diseases, such as Creutzfeldt-Jakob,
kuru and fatal familial insomnia diseases [5–6] and other
neurodegenerative diseases, including Alzheimer’s disease, Par-
kinson’s disease, frontotemporal dementia (FTLD) and Hunting-
ton’s disease [7–8]. In FALS, mutations in the gene encoding the
Cu/Zn superoxide dismutase (SOD1), a ubiquitously-expressed
free-radical defense enzyme, are associated with misfolding of this
normally stable homodimeric protein [9–10]_ENREF_7. Recent
studies have also detected misfolded SOD1 in sporadic forms of
the disease in which SOD1 mutation is excluded [2,11], suggesting
that non-native conformers of SOD1 may participate in a common
pathological mechanism shared by all types of ALS. In addition to
SOD1, heritable mutation of two other genes are implicated in
FALS, and associated with protein mislocalization and aggrega-
tion: the RNA-processing proteins fused in sarcoma (FUS),
originally named translocated in liposarcoma (TLS), and TAR-
DNA binding protein 43 (TDP43) [12–14]_ENREF_10_EN-
REF_10. FUS/TLS and TDP43 are primarily nuclear proteins
that participate in common heteromultimeric complexes [15]
involved in RNA transcription, translation, splicing, nucleo-
cytoplasmic shuttling, transport for local translation, and stress
granule formation [16]. These proteins belong to the family of
heterogeneous nuclear ribonucleoproteins, which are thought to
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Under pathological circumstances, the predominantly nuclear
FUS/TLS and TDP43 are redistributed to the cytosol wherein
they participate in abnormal protein-protein association in this
aberrant locale [18–19]. TDP43 can accumulate in the neuronal
cytosol in other neurodegenerative diseases (e.g. Alzheimer’s
disease), in which it may be a marker of cell stressors [16].
Moreover, naturally occurring mutations in FUS/TLS (hereafter
referred to as FUS) and TDP43 lead to formation of cytoplasmic
aggregates that are associated with a limited number of heritable
syndromes, including ALS [16].
In this study, we tested the hypothesis that FUS and TDP43
gain new pathogenic functions upon accumulation in the cytosol
that directly or indirectly includes misfolding of SOD1. We
detected axonal misfolded SOD1 in a spinal cord from a FUS-
FALS patient, and from SALS patients with TDP43 pathology.
We also used HA-tagged FUS and TDP43 to demonstrate that
expression of cytosolic mutant FUS/TLS or TDP43 is associated
with misfolding of endogenous human wild-type SOD1, as
detected by SOD1 misfolding-specific antibodies directed against
a disordered electrostatic loop [20–21], or monomerized and
oxidized SOD1 [22]. Furthermore, over-expression of wild-type
TDP43, but not wild-type FUS, is also associated with cytosolic
localization and SOD1 misfolding.
Results
SOD1 Misfolding in SOD1-FALS, FUS-FALS and SALS
with TDP43 Pathology
Immunohistochemistry was performed on formalin-fixed paraf-
fin-embedded cervical spinal cord sections from FALS and SALS
patients (Figure 1) using the mouse monoclonal disease specific
epitope antibodies (mAb DSE) 10E11C11 or 3H1, both generated
against a linear peptide corresponding to a structurally disrupted
SOD1 electrostatic loop [9,20] detectable only when the protein is
misfolded in disease [20–21]. Cases of FALS with SOD1
mutations (N=5) had the most extensive accumulation of
misfolded SOD1 in neuronal cytoplasmic inclusions, dystrophic
swollen axons and normal sized axons (Figure 1A). Cases of SALS
with TDP43 pathology (N=3) had misfolded SOD1 in only a small
number of normal sized axons as a consistent feature (Figure 1B).
A case of FALS with the R521C-FUS mutation, with a known
display of substantial cytoplasmic FUS localization and negative
for TDP43 pathology [13,23], revealed an intermediate amount of
misfolded SOD1 accumulation in normal sized axons in the
ventral grey matter (Figure 1C) and occasional swollen axons in
the corticospinal tract (Figure 1D), but not within neuronal
perikarya. We further used 10E11C11 to demonstrate immuno-
reactivity for misfolded SOD1 in non-SOD1 FALS (N=3) and in
SALS (N=20), but not in normal controls (N=5) (Table 1). All
the available demographic and clinical information for these
samples are presented in Table S1.
Cytosolic FUS or TDP43 and SOD1 Misfolding in
Neural Cells
In order to examine the effects of aberrantly localized FUS and
TDP43 on the folding of human wild-type SOD1 (wtSOD1), we
transfected human neuroblastoma SH-SY5Y cells with expression
constructs of wild-type and mutant FUS and TDP43, including
the naturally occurring FUS cytosol-localizing truncation mutation
R495x [24] and the missense mutant P525L [12,18], as well as the
experimentally-engineered cytosol-localizing triple missense tan-
dem TDP43 mutation (K82A, R83A, K84A) in the nuclear
localization signal (NLS; mutant named DNLS-TDP43) [25].
Figure 2 confirms the expression of all transfected constructs by
showing that probing the immunoblot with HA-Tag antibody
detects only the exogenous FUS and TDP43 protein, whereas
probing with FUS- and TDP43- specific antibodies leads to
detection of both the endogenous and exogenous proteins.
Endogenous FUS is seen as a faint band in all the SH-SY5Y cell
lysate samples, whereas the darker bands include the exogenous
FUS detectable only in wt, R495x, or P525L-FUS expressing cells,
with the truncation mutant being smaller in mass. Endogenous
TDP43 is also detected in all SH-SY5Y cell lysate samples, with wt
and dNLS-TDP43 transfected cells showing significantly more
immunoreactivity.
We have found that murine wtSOD1 is not efficiently
misfolded by human mutant SOD1 [26]. To recapitulate as best
as possible in primary neural cells the potential effect of FUS
and TDP43 on the folding of human wtSOD1, E12–14
dissociated spinal cord cultures were prepared from transgenic
mice expressing human wtSOD1. We did not select for neurons
exclusively as the expert consensus is that ALS is a non-cell
autonomous disease, that is both neurons and non-neuronal
cells participate in the pathogenesis [27]. In the human SH-
SY5Y cell line, endogenously expressed or transfection-driven
wtFUS and wtTDP43 localize to the nucleus by immunocyto-
chemistry (Figure 3A, 3B; Figure 4A, 4B; Figure S1), although
a minor fraction of over-expressed wtTDP43 appeared in the
cytosol. In SH-SY5Y cells and in primary neural cultures,
expression of extranuclear FUS mutants R495x and P525L, or
the TDP43 mutant, DNLS-TDP43, was associated with
endogenous SOD1 misfolding in the cytosol of the same cells
as detected by reactivity with the SOD1 DSE mAb 3H1
(Figure 3 and Figure 4). Five to seven percent of SH-SY5Y cells
and , 1% of primary neural cells were successfully transfected
and displayed cytosolic localization of transgenic mutant FUS
and TDP43, of which the majority (range 50–75%) also
exhibited 3H1 immunoreactivity. Transfected SH-SY5Y cells or
human wtSOD1-expressing primary neural cells demonstrate the
presence of 3H1-immunoreactive misfolded SOD1 in FUS-
(Figure 3C–F) or TDP43- (Figure 4A–D) transfected cells, but
not in non-transfected cells in the same fields of view.
Differences in SOD1 misfolding were observed between wtFUS
and wtTDP43 transfection: exogenous wtFUS was confined to
the nucleus in SH-SY5Y and primary neural cells without
detectable 3H1 immunoreactivity in these cells (Figure 3A, 3B),
whereas exogenous wtTDP43 was predominantly distributed in
the nuclear compartment with trace cytoplasmic immunoreac-
tivity, and was strongly associated with SOD1 misfolding in the
same cells (Figure 4A, 4B).
Quantification of FUS- or TDP43-associated SOD1
Misfolding
Quantitative immunoprecipitation of non-denatured lysates
from transfected SH-SY5Y cells was performed with magnetic
beads coupled with DSE 3H1 mAb and the SOD1 misfolding/
oxidation-specific DSE 10C12 mAb, generated against a cysteic
acid-substituted SOD1 exposed dimer interface (SEDI) peptide
[22,26]_ENREF_25 (Figure 5A). Specific immunoprecipitation
of conformation-specific 3H1 and 10C12 mAbs was controlled
by irrelevant mouse IgG mAb. Transfection of cells with the
pCINeo empty vector (ev) lacking coding DNA provided an
additional negative control for cell stressors inherent in the
protocol. SOD1 misfolding specific 3H1 and 10C12 mAbs
immunoprecipitated appreciable levels of misfolded and/or
oxidized endogenous SOD1 in cultured cells transfected with
cytosolic mutants R495x- and P525L- FUS compared to ev
Mislocalization of FUS and TDP43 Misfolds SOD1
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p,0.001, respectively). No misfolded SOD1 was detected in
cells transfected with wtFUS (3H1: p.0.5 and 10C12: p.0.7;
compared to ev). Lysates of SH-SY5Y cells transfected with wt-
or DNLS- TDP43 presented misfolded SOD1 (Figure 5D–E;
3H1: p,0.002, p,0.001 and 10C12: p,0.001, p,0.001,
respectively). Considering that only 5% of the SH-SY5Y cells
were successfully transfected, the immunoprecipitation data
suggests that nearly 20–50% of the total cellular SOD1 is
misfolded in mutant FUS and TDP43 expressing cells. No
Figure 1. Misfolded SOD1 immunohistochemistry in ventral grey matter and corticospinal tracts of cervical spinal cord of ALS
patients. (A) Cases of FALS with SOD1 mutations show extensive accumulation of misfolded SOD1 in swollen and normal sized axons as well as in
the perikarya of some lower motor neurons (inset). (B) Cases of SALS with TDP43 pathology had misfolded SOD1 accumulation only in small numbers
of normal sized axons (arrows). (C, D) In the case of FALS with FUS mutation misfolded SOD1 accumulated in some swollen axons in the ventral grey
matter (C, arrows) and a moderate number of normal sized axons in corticospinal tract (D, arrows). Scale bar, 60 mm( A, C); 30 mm( B, D).
doi:10.1371/journal.pone.0035050.g001
Table 1. Detection of misfolded SOD1 in various structures and regions by immunohistochemistry.
Structure/Region SOD1-FALS non-SOD1 FALS non-SOD1 SALS Control
Neuronal cytoplasmic inclusions ++ 222
Axonal swellings ++ 222
Axons +++ ++ + 2
Corticospinal tract +++ ++ ++ 2
Other tracts ++ + 2
Motor Roots ++ + + 2
Relative abundance of DSE antibody (10E11C11) staining in various regions and structures of patient spinal cord sections (N=5 normal control; N=5 SOD1-FALS; N=3
non-SOD1 FALS including R521C-FUS; N=20 non-SOD1 SALS). Neuronal cytoplasmic inclusions, axonal swellings and axons are sub-structures within the ventral grey
matter. Positive staining in corticospinal tract, other tracts and motor roots was in axons. –, no staining; +, some staining; ++, moderate staining; +++, abundant staining.
doi:10.1371/journal.pone.0035050.t001
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when SH-SY5Y cells were transfected with green fluorescence
protein (GFP, Figure S2), consistent with the specific effect of
FUS and TDP43 cytosolic accumulation on SOD1. The
immunoprecipitation studies are in agreement with the immu-
nocytochemical studies, in that cytosolic localization of mutant
FUS and TDP43, and wtTDP43, but not wtFUS, is associated
with SOD1 misfolding.
Figure 2. Expression of transfected wild-type and mutant FUS and TDP43 in SH-SY5Y cells. The immunoblot on the left was probed with
antibody specific to HA-tag, detecting only the exogenously expressed proteins in these samples. The empty vector (ev; pCINeo) control does not
display detectable immunoreactivity with the HA-tag antibody, while both exogenous FUS and TDP43 are detected as 43 kDa and 72 kDa bands,
respectively. Top and bottom portions of the immunoblot on the right were probed using FUS and TDP43 specific antibodies, respectively, detecting
both the endogenous and exogenous proteins. Endogenous FUS and TDP43 are detected in all samples; however, stronger signals, corresponding to
the over-expressed protein, are detected in the transfected samples.
doi:10.1371/journal.pone.0035050.g002
Figure 3. Transfection of mutant FUS is associated with SOD1 misfolding by immunocytochemistry. Human neuroblastoma SH-SY5Y
cells and primary neural cultures expressing human wtSOD1 were stained for HA-Tag (red), misfolded SOD1 (green), and Hoechst33342 nuclear
counterstain (blue). (A, B) Human wild-type FUS localizes in the nucleus and no misfolded SOD1 is detected. (C–F) Both of the truncated variant,
R495x-FUS (B, C), and point mutation variant, P525L-FUS (E, F), localize in the cytosol and are associated with misfolding of SOD1 in the same cells, as
detected by the immunocytochemistry with the 3H1 SOD1 misfolding-specific mAb. Exogenous FUS was detected using the N-terminal HA-tag.
Arrows point to transfected cells. Scale bar, 20mm.
doi:10.1371/journal.pone.0035050.g003
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Previous studies suggest that a neurotoxic gain of function is
incurred by pathological isoforms of FUS and TDP43 that
accumulate in the cytosol of afflicted cells [4,15]. Here we report
that motor axons from R521C FUS-FALS and wtTDP43-SALS
patient spinal cords are immunoreactive for misfolded SOD1 by
immunohistochemistry with SOD1 misfolding-specific mAbs.
Using these same antibodies we found that transfection-driven
expression of cytosolic mutants of FUS or TDP43 in vitro is
associated with SOD1 misfolding by immunocytochemistry and
immunoprecipitation. Motor axonal misfolded SOD1 was also
observed by immunohistochemistry in SALS, in which extranu-
clear non-mutant TDP43 is ubiquitinated and accumulates in
a proteolytically cleaved and detergent insoluble form [14,23,28],
and in neural cells in which wtTDP43 is over-expressed.
Commensurate with these findings, motor neuron disease is
induced by transgenic over-expression in rodents of human
mutant FUS or TDP43 [29], and by expression of wtTDP43
[30–32] but not wtFUS [29]. Cytosolic accumulation of wtFUS
aggregates is not observed in SALS [13], and we did not detect
SOD1 misfolding in neural cells over-expressing wtFUS. Given
the concordance between the neuropathological immunohisto-
chemistry, and the immunocytochemistry and immunoprecipita-
tion of cultured cells, we conclude that cytoplasmic accumulation
of FUS and/or TDP43 is associated with misfolding of human
wtSOD1, both in vivo and in vitro.
Is extranuclear accumulation of FUS and TDP43 a cause or
consequence of SOD1 misfolding, and if causal is the
interaction direct or indirect? Consistent with our studies in
cell culture and in human FUS-FALS, a causal association is
tenable between SOD1 misfolding and cytosolic accumulation of
mutant FUS, or mutant and wtTDP43. However, accumulation
of non-mutated TDP43 (but not wtFUS) in SALS spinal
neuronal cytosol may also be, at least partially, a consequence of
cell stress, as the pathology also appears in diverse diseases
including Alzheimer’s disease and frontotemporal lobar de-
mentia [33]. Recent work has shown that TDP43 aggregation
and neurotoxic cleavage may be triggered by free radical stress
secondary to mitochondrial dysfunction [34–35], a concomitant
of cellular mutant SOD1 expression [20–21]. Immunohisto-
chemical differences in the distribution and abundance of
misfolded SOD1 in FUS-FALS and TDP43-SALS are poten-
tially consistent with the notion of different mechanisms of
SOD1 misfolding.
Concerning the question of direct or indirect interaction of
cytosolic FUS and/or TDP43 with SOD1, we believe that the
lack of immunohistochemical co-distribution of misfolded SOD1
(in motor axons) and FUS or TDP43 (in perikarya) in spinal
motor neurons from FUS-FALS patients, as well as from SALS
patients with TDP43 deposits [23], suggests that an indirect
mechanism of SOD1 misfolding in vivo. Indirect mechanisms for
FUS- or TDP43-induced misfolding of SOD1 include chaper-
one titration, for example TDP43 and SOD1-associated heat
shock proteins HSP-B8 [36] and HSP70 [37]. Furthermore,
FUS and TDP43 participate in a complex that modulates
expression of histone deacetylase (HDAC) 6, implicated in
clearance of misfolded proteins through the autophagy pathway
[15,38]. Both cytosolic mutant FUS and TDP43 have previously
been suggested to sequester endogenous FUS [13,39] and
TDP43 [25], therefore depleting the nucleus of the respective
protein.
Figure 4. SOD1 misfolding in wild-type and DNLS-TDP43-transfected SH-SY5Y cells and human wtSOD1 expressing primary neural
cells. SH-SY5Y cells and primary neural cells stained against HA-tag (transfected TDP43; red), misfolded SOD1 (green), and Hoechst33342 (blue)
nuclear counterstain. Human wtTDP43 predominantly localizes in the nucleus (A, B) while the mutant DNLS-TDP43 localizes in the cytosol (C, D).
Both variants of TDP43 are associated with misfolding of the endogenous SOD1 in the same cells, as detected by 3H1 immunoreactivity. Arrows point
to transfected cells. Scale bar, 20mm.
doi:10.1371/journal.pone.0035050.g004
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accumulation of mutant FUS or TDP43 in FUS-FALS and
TDP43-FALS, respectively, as well as of wtTDP43 in SALS.
However, SOD1-FALS, wherein motor axons display prominent
inclusions of misfolded SOD1, is not associated with cytosolic
accumulation of FUS or TDP43 [16]. We propose that SOD1
misfolding could constitute a critical molecular event in the unified
pathogenesis of FALS and SALS, distal to FUS or TDP43
cytosolic accumulation. Given that misfolded mutant and
wtSOD1 can template the misfolding of natively folded wtSOD1
and propagate from cell to cell in vitro [9,40], an attractive
speculation is that stochastic induction of a competent template by
mutant SOD1, FUS, or TDP43 could trigger the propagation of
SOD1 misfolding in FALS and SALS. Such propagation of SOD1
misfolding by an SOD1 template is also consistent with the lack of
congruent distribution in ALS spinal neurons. Misfolded SOD1
acquires a toxic gain of function, which may include generation of
reactive oxygen and nitrogen species by direct enzymatic activity
[41] and by induction of mitochondrial dysfunction [21]. In SALS,
cytoplasmic accumulation of wtTDP43, as a local response to
injury or cell stress, may also induce a productive template of
misfolded SOD1, or may be a toxic consequence of SOD1
misfolding. The confirmation of a final common molecular
pathway in ALS, mediated by the propagated misfolding of
SOD1, would have important implications for the effective
treatment of this devastating disease.
Figure 5. Quantitative immunoprecipitation of misfolded human SOD1 in SH-SY5Y cells transfected with wild-type or mutant FUS
and TDP43. (A) Representative immunoblots of immunoprecipitations. SOD1 proteins from transfected (48 h) and untransfected SH-SY5Y cell
lysates were precipitated using pan-SOD1 antibody, SOD100 (rabbit polyclonal), and SOD1 misfolding-specific mouse monoclonal antibodies, 3H1
and 10C12. rIgG was used as isotype control for SOD100, and mIgG2a was used as isotype control for the DSE antibodies. Blots were probed with
pan-SOD1 antibody. Framed bands show FUS, and TDP43 transfection efficiency of the indicated construct, as was detected by probing with
antibody to HA-tag. (B–E) Show percentage of immunoprecipitable misfolded SOD1 (out of the total precipitable SOD1) using 3H1 (B, D) and 10C12
(C, E) from lysates of transfected SH-SY5Y cell cultures. Appreciable differences are indicated (*, p,0.01). N=5 for each of wtFUS, R495x- and P525L-
FUS. N=6 for each of ev, wtTDP43 and DNLS-TDP43. Error bars represent s.e.m.
doi:10.1371/journal.pone.0035050.g005
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Cloning and Mutagenesis
FUS and TDP43 plasmids (Plasmid #21827, AddGene,
Cambridge, MA; MHS1010-98051213, Open Biosystems, Hunts-
ville, AL), were amplified and modified using PCR-based site-
directed mutagenesis. To avoid steric hindrance effects due to
large tagging probes, the small hemagglutinin (HA)-tag, derived
from amino acids 98–106 of human influenza hemagglutinin [42],
was used to label the amino-termini of our wild-type and mutant
constructs so as to distinguish from endogenous proteins. HA-
tagging has been successfully used in other studies for detection of
exogenous FUS [13,18] and TDP43 [15,43]. Amino terminal HA-
tag was fused to FUS and TDP43 using: 59-CCGCTCGAGGC-
CACCATGTACCCATACGATGTTCCAGAT-
TACGCTGCCTCAAACGATTATACC and 59-
CCGCTCGAGGCCACCATGTACCCATACGATGTTCCA-
GATTACGCTTCTGAATATATTCGG, respectively. Trunca-
tion R495x- and point P525L-mutations were created using the
following reverse oligonucleotide primers: 59- CTAGTCTAGAT-
TAGAAGCCTCCACGGTCand59-CTAGTCTAGATTAATA-
CAGCCTCTCCCTGCG, respectively. For the generation of
missense tandem mutations in TDP43 (K82A, R83A, and K84A),
oligonucleotide primers 59-CCAAAAGATAACGCAGCAG-
CAATGGATGAGACAGATGC, and 59-GCATCTGTCT-
CATCCATTGCTGCTGCGTTATCTTTTGG were used.
Tissue Culture and DNA Transfections
We cultured human neuroblastoma SH-SY5Y cells (ATCC,
Manassas, VA) in Dulbecco’s Modified Eagle Medium (DMEM)
supplemented with 10% FBS, 10 U/ml penicillin, 10 U/ml
streptomycin and 2 mM L-glutamine. Cells were transiently
transfected using the low cytotoxicity Lipofectamine LTX
(Invitrogen, Carlsbad, CA), according to manufacturer’s instruc-
tions. For immunofluorescence and immunoprecipitation experi-
ments, cells were cultured in 24-well and 10 cm tissue culture-
treated plates, respectively.
Mouse Primary Spinal Cord Culture
Experiments involving animals were conducted according to the
Canadian Council on Animal Care guidelines and have been
approved by the Animal Care Committee of the University of
British Columbia (Approval ID: A10-0212). Pregnant C57 BL/6
female mice (Strain: B6SJL-Tg(SOD1)2Gur/J, Stock:002297;
Jackson Laboratories, Bar Harbor, ME) were sacrificed according
to the guidelines of the Institutional Animal Care and Use
Committee (IACUC). Primary cerebral cortical cultures were
prepared from 12–14 day fetal mice using minor modification of
an established protocol [44]. Following embryo genotyping,
cervical, thoracic and lumbar- regions of the spinal cord were
dissected out in Ca
2+/Mg
2+-free Hanks Balanced Salts (GIBCO
BRL, Grand Island, NY). Meninges were removed and the tissue
was transferred to 0.25% trypsin (GIBCO BRL, Grand Island,
NY) and digested at 37uC for 15 min. Tissue was then
resuspended in DMEM (GIBCO BRL, Grand Island, NY) plus
10% fetal bovine serum (GIBCO BRL, Grand Island, NY) and
triturated 4–6 times through a fire-polished tip. The supernatant
was centrifuged at 200 6g for 45 sec. Pelleted neural cells were
resuspended in Neurobasal media (GIBCO BRL, Grand Island,
NY), B27 (GIBCO BRL, Grand Island, NY), 2 mM L-glutamine
(Sigma, Saint Louis, MO) and seeded at a density of 2610
5 cells/
well onto poly-D-lysine (Sigma, Saint Louis, MO) coated #1.5
coverslips in 24-well plates. Cultures were maintained in serum-
free Neurobasal-B27 medium, and one-half of medium was
replaced on day 3 or 4 with equal volume of fresh medium. Cells
were transfected at 5 DIV using Lipofectamine LTX with Plus
reagent (Invitrogen, Carlsbad, CA).
Embryo Genotyping
To mimic the scenario of association between human wtSOD1,
and FUS and TDP43 in primary neurons, neural cultures were
prepared from human wtSOD1 expressing C57 BL/6 Tg mouse
embryos. Tissue was collected in 200 ml of lysis buffer (0.45%
Nonidet P240, 0.45% Tween 20, 50 mM KCl, 10 mM Tris-HCl
in water, pH 8.8) with 2 ml of Proteinase K (Invitrogen, Carlsbad,
CA), and incubated at 60uC with constant shaking for 2 h. The
sample was then incubated at 96uC for 10 min to inactivate the
proteinase K. Immediately upon inactivation, the PCR mixture
was prepared using 2 ml of lysis buffer containing DNA for
genotyping. Two sets of primers were used for the PCR reaction:
59-CATCAGCCCTAATCCATCTGA and 59-CGCGACTAA-
CAATCAAAGTGA (hwtSOD1 specific primers); 59-TGGA-
CAGGACTGGACCT CTGCTTTCCTAGA and 59-TA-
GAGCTTTGCCACATCACAGGTCATTCAG (internal mouse
control).
Immunofluorescence
In order to detect specifically misfolded SOD1, we used the
disease specific epitope (DSE) monoclonal antibody 3H1
[9,20,26]. SH-SY5Y cells were placed on glass cover-slips (#1.5)
in a 24-well plate one day prior to transfection. 48 h post
transfection, cells were washed once with ice-cold PBS and fixed in
4% paraformaldehyde (in PBS, pH 7.4) for 15 min at room
temperature. Fixed cells were then permeabilized twice for 5 min
in PBST (0.3% Triton X-100 in PBS) and incubated with 2 mg/ml
mouse monoclonal 3H1, as well as one of 10 mg/ml rabbit TDP43
specific (ProteinTech Group Inc., Chicago, IL), FUS specific
(Abcam, Cambridge, MA) or HA-tag specific (Thermo Scientific,
Rockford, IL) polyclonal antibody, diluted in PBST with 2%
normal goat serum, for 1 h at room temperature. Cells were then
washed twice in PBST and incubated with appropriate secondary
antibody conjugated to Alexa Fluor 488 (green) or Alexa Fluor 647
(red) dyes (Invitrogen, Carlsbad, CA; both diluted 1:1,000) for 1 h
at room temperature in the dark. For DNA counter-staining,
bisBenzimide H33342 trihydrochloride (Hoechst 33342) was used
at 2 mg/ml (in PBST). Hoechst33342-stained cells were incubated
for 15 min at room temperature after the first wash of secondary
antibody, followed by two more washes with PBS. Cells were
mounted on a glass slide in a drop of Fluoromount-G (South-
ernBiotech) and allowed to dry overnight before imaging. Images
were viewed and captured on an Olympus FluoView FV1000
confocal microscope (Olympus Canada) using FV1000 ASW
software.
Immunoprecipitation
Transfected cells growing on 10 cm dishes were washed twice in
ice-cold PBS and collected by centrifugation (5 min at 1,000 6g,
4uC). We lysed the cell pellets in 300 ml lysis buffer (PBS, 0.5%
sodium deoxycholate (DOC), 0.5% Triton X-100 and 1x
complete, EDTA-free protease inhibitor cocktail (Roche Diag-
nostics, Mannheim, Germany) for 2 min on ice, followed by
centrifugation for 5 min at 1,0006g, 4uC. Lysate was removed to
a fresh tube. For immunoprecipitation experiments, 100 ml cell
lysate was added to 0.65 ml microfuge tubes followed by addition
of 10 ml of antibody-coupled M-280 Tosyl-activated magnetic
Dynabeads (Invitrogen, Carlsbad, CA). Tubes were mixed and
incubated for 3 h at room temperature with constant rotation.
Beads were then washed three times with 150 ml RIPA buffer
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0.5% DOC, 0.1% SDS) with brief vortexing in-between washes,
and boiled in SDS sample buffer containing 1% b -mercaptoetha-
nol for 5 min. 1 ml of lysate was added directly into SDS sample
buffer, boiled and used as a pre-IP control.
Preparation of Antibody-coupled Magnetic Dynabeads
175 ml beads were washed twice in 1 ml PBS and resuspended
in a final volume of 1 ml PBS. 80 mg DSE monoclonal antibody,
or 50 mg pan-SOD1 (SOD100; Assay Designs, Ann Arbor, MI)
polyclonal antibody was added to beads and incubated for 24 h at
37uC with constant rotation. Beads were then washed twice in
1 ml PBS with 0.1% BSA and incubated in 1 ml blocking buffer
(0.2 M Tris-HCl, pH 8.5, 0.1% PBS) for 4 h at 37uC with
constant rotation. Beads were then washed again in 1ml PBS with
0.1% BSA, resuspended in a final volume of 500 ml of PBS and
stored at 4uC.
Immunohistochemistry
We performed Immunohistochemistry for misfolded SOD1 on
5 mm thick sections of formalin fixed, paraffin embedded tissue
sections using the Ventana BenchMarkH XT automated staining
system (Ventana, Tuscon, AZ) and developed with aminoethyl-
carbizole (AEC). The primary antibodies were DSE2-10E11C11
(1:500, following microwave pre-treatment) and 3H1 (1:50,
following standard heat retrieval).
Immunoblotting and Quantification
Boiled samples were analyzed on 4–20% acrylamide Tris-
Glycine precast gels for 2 h at 125 V (Invitrogen, Carlsbad, CA).
Proteins were electrophoretically transferred to PVDF membrane,
blocked with 5% milk in Tris-buffered saline, 0.1% Tween-20
(TBST) for 30 min and incubated with 1 mg/ml pan-SOD1
antibody (SOD100; Assay Designs, Ann Arbor, MI) in 5% milk-
TBST overnight at 4uC with constant rocking. Membranes were
washed with TBST followed by 1 h incubation with donkey anti-
rabbit IgG horseradish peroxidase linked whole antibody (GE
Healthcare, Buckinghamshire, UK) diluted 1:5,000 in 5% milk-
TBST. Membranes were then developed with SuperSignal West
Femto chemiluminescent substrate (Thermo Scientific, IL) and
visualized using a VersaDoc Imager (Bio-Rad Laboratories,
Hercules, CA); signal intensities were quantified using Quantity
One software (Bio-Rad Laboratories, Hercules, CA). All images
were acquired with no digital or biological signal saturation. In
order to determine the percentage of misfolded SOD1 in each
sample, quantified immunoprecipitate was compared to mIgG
control, and normalized to total immunoprecipitable SOD1. The
percentage of misfolded SOD1 in cell lysates is determined by the
ratio of the true DSE-mAb immunoprecipitation to that of IgG2a-
control, followed by normalization to total SOD1 in the lysates.
Statistical Analysis
Without any assumption regarding the distribution underlying
our small samples we applied nonparametric tests (Kruskal-Wallis
and Mann-Whitney-U tests). The significance thresholds were also
adjusted for multiple comparisons by the Bonferroni correction to
maintain the familywise error rate and keep the alpha level at 0.05.
Supporting Information
Figure S1 Normal distribution of FUS and TDP43 in the
cell. (A, B) Untreated human neuroblastoma SH-SY5Y cells (A)
and primary neural cells (B) probed for misfolded SOD1 (green)
and Hoechst 33342 nuclear counter-stain (blue). Staining of the
respective cells against FUS and TDP43 (top, bottom), shows
completely nuclear localization of these proteins with no detect-
able misfolded SOD1. Scale bar, 20 mm.
(TIF)
Figure S2 Expression of GFP in SH-SY5Y cells. (A)
Human neuroblastoma cells transiently expressing the exogenous
GFP protein (green) do not contain misfolded SOD1, as is evident
by staining with 3H1 (red). (B) Immunoprecipitations of SOD1
from SH-SY5Y cultures that were transfected with the GFP
vector, show pull-down of total SOD1 using the pan-SOD1,
SOD100 antibody, but no presence of misfolded SOD1, as is seen
by lack of pull-down of both 3H1 and 10C12. (C) Presence of
normalized % of misfolded SOD1 in eGFP transfected cultures is
comparable to ev control. Error bars show s.e.m. Scale bar,
20 mm.
(TIF)
Table S1 Clinical and demographic information on
spinal cord tissues used for immunohistochemistry. All
tissues were collected at autopsy within 48 hours of patient death
and used directly for IHC analysis. n/a, not available.
(TIF)
Acknowledgments
We thank Maja Filipovic and Margaret Luk for their excellent technical
assistance.
Author Contributions
Conceived and designed the experiments: EP NRC. Performed the
experiments: EP LG IRM. Analyzed the data: EP LG MY IRM NRC.
Contributed reagents/materials/analysis tools: EP LG MY JW IRM NRC.
Wrote the paper: EP LG MY IRM NRC.
References
1. Cleveland DW (1999) From Charcot to SOD1: mechanisms of selective motor
neuron death in ALS. Neuron 24: 515–520.
2. Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, et al. (2010)
Wild-type and mutant SOD1 share an aberrant conformation and a common
pathogenic pathway in ALS. Nat Neurosci 13: 1396–1403.
3. Munoz DG (2010) FUS mutations in sporadic juvenile ALS: another step toward
understanding ALS pathogenesis. Neurology 75: 584–585.
4. Lagier-Tourenne C, Cleveland DW (2009) Rethinking ALS: the FUS about
TDP–43. Cell 136: 1001–1004.
5. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie.
Science 216: 136–144.
6. Keohane C (1999) The human prion diseases. A review with special emphasis on
new variant CJD and comments on surveillance. Clin Exp Pathol 47: 125–132.
7. Selkoe DJ (2003) Folding proteins in fatal ways. Nature 426: 900–904.
8. Guest WC, Silverman JM, Pokrishevsky E, O’Neill MA, Grad LI, et al. (2011)
Generalization of the prion hypothesis to other neurodegenerative diseases: an
imperfect fit. J Toxicol Environ Health A 74: 1433–1459.
9. Cashman N (2010) Prion-like Propagation of SOD1 Misfolding in Amyotrophic
Lateral Sclerosis Prion 4: 1.
10. Banci L, Bertini I, Boca M, Calderone V, Cantini F, et al. (2009) Structural and
dynamic aspects related to oligomerization of apo SOD1 and its mutants. Proc
Natl Acad Sci U S A 106: 6980–6985.
11. Forsberg K, Jonsson PA, Andersen PM, Bergemalm D, Graffmo KS, et al.
(2010) Novel antibodies reveal inclusions containing non-native SOD1 in
sporadic ALS patients. PLoS One 5: e11552.
12. Kwiatkowski TJ, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, et al.
(2009) Mutations in the FUS/TLS gene on chromosome 16 cause familial
amyotrophic lateral sclerosis. Science 323: 1205–1208.
13. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, et al. (2009)
Mutations in FUS, an RNA processing protein, cause familial amyotrophic
lateral sclerosis type 6. Science 323: 1208–1211.
14. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al.
(2006) Ubiquitinated TDP–43 in frontotemporal lobar degeneration and
amyotrophic lateral sclerosis. Science 314: 130–133.
Mislocalization of FUS and TDP43 Misfolds SOD1
PLoS ONE | www.plosone.org 8 April 2012 | Volume 7 | Issue 4 | e3505015. Kim SH, Shanware NP, Bowler MJ, Tibbetts RS (2010) Amyotrophic lateral
sclerosis-associated proteins TDP–43 and FUS/TLS function in a common
biochemical complex to co-regulate HDAC6 mRNA. J Biol Chem 285:
34097–34105.
16. Lagier-Tourenne C, Polymenidou M, Cleveland DW (2010) TDP–43 and FUS/
TLS: emerging roles in RNA processing and neurodegeneration. Hum Mol
Genet 19: R46–64.
17. Pesiridis GS, Lee VM, Trojanowski JQ (2009) Mutations in TDP–43 link
glycine-rich domain functions to amyotrophic lateral sclerosis. Hum Mol Genet
18: R156–162.
18. Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, et al. (2010) ALS-
associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated
nuclear import. EMBO J 29: 2841–2857.
19. Moisse K, Volkening K, Leystra-Lantz C, Welch I, Hill T, et al. (2009)
Divergent patterns of cytosolic TDP–43 and neuronal progranulin expression
following axotomy: implications for TDP–43 in the physiological response to
neuronal injury. Brain Res 1249: 202–211.
20. Vande Velde C, Miller TM, Cashman NR, Cleveland DW (2008) Selective
association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of
mitochondria. Proc Natl Acad Sci U S A 105: 4022–4027.
21. Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, et al. (2010) Misfolded
mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of
inherited ALS. Neuron 67: 575–587.
22. Rakhit R, Robertson J, Vande Velde C, Horne P, Ruth DM, et al. (2007) An
immunological epitope selective for pathological monomer-misfolded SOD1 in
ALS. Nature medicine 13: 754–759.
23. Mackenzie IR, Rademakers R, Neumann M (2010) TDP–43 and FUS in
amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9:
995–1007.
24. Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, et al. (2010) Mutant FUS
proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.
Hum Mol Genet 19: 4160–4175.
25. Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, et al. (2008)
Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP–43)
induces disease-like redistribution, sequestration, and aggregate formation. J Biol
Chem 283: 13302–13309.
26. Grad LI, Guest WC, Yanai A, Pokrishevsky E, O’Neill MA, et al. (2011)
Intermolecular transmission of superoxide dismutase 1 misfolding in living cells.
Proc Natl Acad Sci U S A 108: 16398–16403.
27. Ilieva H, Polymenidou M, Cleveland DW (2009) Non-cell autonomous toxicity
in neurodegenerative disorders: ALS and beyond. J Cell Biol 187: 761–772.
28. Kwong LK, Uryu K, Trojanowski JQ, Lee VMY (2008) TDP–43 proteino-
pathies: neurodegenerative protein misfolding diseases without amyloidosis.
Neuro-Signals 16: 41–51.
29. Huang C, Zhou H, Tong J, Chen H, Liu Y-J, et al. (2011) FUS Transgenic Rats
Develop the Phenotypes of Amyotrophic Lateral Sclerosis and Frontotemporal
Lobar Degeneration. PLoS genetics 7: e1002011.
30. Ash PEA, Zhang Y-J, Roberts CM, Saldi T, Hutter H, et al. (2010) Neurotoxic
effects of TDP–43 overexpression in C. elegans. Human molecular genetics 19:
3206–3218.
31. Barmada SJ, Skibinski G, Korb E, Rao EJ, Wu JY, et al. (2010) Cytoplasmic
mislocalization of TDP–43 is toxic to neurons and enhanced by a mutation
associated with familial amyotrophic lateral sclerosis. The Journal of
neuroscience : the official journal of the Society for Neuroscience 30: 639–649.
32. Xu YF, Gendron TF, Zhang YJ, Lin WL, D’Alton S, et al. (2010) Wild-type
human TDP–43 expression causes TDP–43 phosphorylation, mitochondrial
aggregation, motor deficits, and early mortality in transgenic mice. J Neurosci
30: 10851–10859.
33. Wilson AC, Dugger BN, Dickson DW, Wang DS (2011) TDP–43 in aging and
Alzheimer’s disease - a review. Int J Clin Exp Pathol 4: 147–155.
34. Braun RJ, Sommer C, Carmona-Gutierrez D, Khoury CM, Ring J, et al. (2011)
Neurotoxic 43-kDa TAR DNA-binding Protein (TDP–43) Triggers Mitochon-
drion-dependent Programmed Cell Death in Yeast. J Biol Chem 286:
19958–19972.
35. Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderwyde T, Citro A, et al. (2010)
Tar DNA binding protein-43 (TDP–43) associates with stress granules: analysis
of cultured cells and pathological brain tissue. PLoS One 5: e13250.
36. Crippa V, Sau D, Rusmini P, Boncoraglio A, Onesto E, et al. (2010) The small
heat shock protein B8 (HspB8) promotes autophagic removal of misfolded
proteins involved in amyotrophic lateral sclerosis (ALS). Human molecular
genetics 19: 3440–3456.
37. Koyama S, Arawaka S, Chang-Hong R, Wada M, Kawanami T, et al. (2006)
Alteration of familial ALS-linked mutant SOD1 solubility with disease
progression: its modulation by the proteasome and Hsp70. Biochem Biophys
Res Commun 343: 719–730.
38. Boyault C, Zhang Y, Fritah S, Caron C, Gilquin B, et al. (2007) HDAC6
controls major cell response pathways to cytotoxic accumulation of protein
aggregates. Genes Dev 21: 2172–2181.
39. Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, et al.
(2009) A new subtype of frontotemporal lobar degeneration with FUS
pathology. Brain : a journal of neurology 132: 2922–2931.
40. Munch C, O’Brien J, Bertolotti A (2011) Prion-like propagation of mutant
superoxide dismutase-1 misfolding in neuronal cells. Proceedings of the National
Academy of Sciences of the United States of America 108: 3548–3553.
41. Crow JP, Sampson JB, Zhuang Y, Thompson JA, Beckman JS (1997) Decreased
zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase
mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite.
J Neurochem 69: 1936–1944.
42. Hua X, Sakai J, Ho YK, Goldstein JL, Brown MS (1995) Hairpin orientation of
sterol regulatory element-binding protein-2 in cell membranes as determined by
protease protection. J Biol Chem 270: 29422–29427.
43. Seyfried NT, Gozal YM, Dammer EB, Xia Q, Duong DM, et al. (2010)
Multiplex SILAC analysis of a cellular TDP–43 proteinopathy model reveals
protein inclusions associated with SUMOylation and diverse polyubiquitin
chains. Mol Cell Proteomics 9: 705–718.
44. Anderson KN, Potter AC, Piccenna LG, Quah AK, Davies KE, et al. (2004)
Isolation and culture of motor neurons from the newborn mouse spinal cord.
Brain Res Brain Res Protoc 12: 132–136.
Mislocalization of FUS and TDP43 Misfolds SOD1
PLoS ONE | www.plosone.org 9 April 2012 | Volume 7 | Issue 4 | e35050